DE3854502T2 - Gegen hiv-antigene spezifischer monoklonaler antikörper. - Google Patents

Gegen hiv-antigene spezifischer monoklonaler antikörper.

Info

Publication number
DE3854502T2
DE3854502T2 DE3854502T DE3854502T DE3854502T2 DE 3854502 T2 DE3854502 T2 DE 3854502T2 DE 3854502 T DE3854502 T DE 3854502T DE 3854502 T DE3854502 T DE 3854502T DE 3854502 T2 DE3854502 T2 DE 3854502T2
Authority
DE
Germany
Prior art keywords
antigent
monoclonal antibodies
specific monoclonal
against hiv
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3854502T
Other languages
English (en)
Other versions
DE3854502D1 (de
Inventor
Kenneth Kortright
David Hofheinz
Carole Sullivan
Gary Toedter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Coulter Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coulter Corp filed Critical Coulter Corp
Publication of DE3854502D1 publication Critical patent/DE3854502D1/de
Application granted granted Critical
Publication of DE3854502T2 publication Critical patent/DE3854502T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
DE3854502T 1987-11-06 1988-06-10 Gegen hiv-antigene spezifischer monoklonaler antikörper. Expired - Lifetime DE3854502T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/118,145 US4888290A (en) 1987-11-06 1987-11-06 Monoclonal antibody specific to HIV antigens
PCT/US1988/001997 WO1989004376A1 (en) 1987-11-06 1988-06-10 Monoclonal antibody specific to hiv antigens

Publications (2)

Publication Number Publication Date
DE3854502D1 DE3854502D1 (de) 1995-10-26
DE3854502T2 true DE3854502T2 (de) 1996-04-18

Family

ID=22376739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854502T Expired - Lifetime DE3854502T2 (de) 1987-11-06 1988-06-10 Gegen hiv-antigene spezifischer monoklonaler antikörper.

Country Status (13)

Country Link
US (1) US4888290A (de)
EP (1) EP0415920B1 (de)
JP (1) JP2710972B2 (de)
KR (1) KR960016304B1 (de)
CN (1) CN1025219C (de)
AU (1) AU612686B2 (de)
CA (1) CA1339350C (de)
DE (1) DE3854502T2 (de)
ES (1) ES2016427A6 (de)
IE (1) IE61241B1 (de)
IL (1) IL87535A (de)
WO (1) WO1989004376A1 (de)
ZA (1) ZA884651B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104790A (en) * 1987-06-29 1992-04-14 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US4886742A (en) * 1987-06-15 1989-12-12 Coulter Corporation Enzyme immunoassay for detecting HIV antigens in human sera
ZA903492B (en) * 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
US5210181A (en) * 1989-05-15 1993-05-11 Akzo N.V. T-lymphotropic retrovirus peptide
KR930701619A (ko) * 1990-06-01 1993-06-12 레나토 스가르비 인체 면역 결핍 바이러스의 gag 단백질 전구체 p55에 대한 단일클론 항체
US5164293A (en) * 1990-09-25 1992-11-17 Coulter Corporation Monoclonal antibody for detecting HTLV-I, HTLV-II and STLV-I viruses
EP0519866A1 (de) * 1991-06-18 1992-12-23 Ciba-Geigy Ag Antikörper gegen H.I.V.
US5451525A (en) * 1992-02-14 1995-09-19 Coulter Corporation Method and materials for determining particle count in a flow cytometer
US6319665B1 (en) 1994-06-07 2001-11-20 Inverness Medical Technology, Inc. Home test kit and method with telephone verification of results
AU5082698A (en) * 1996-10-23 1998-05-15 Oravax, Inc Heat inactivation of viruses in antibody preparations
US5891994A (en) * 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US5902722A (en) * 1997-12-05 1999-05-11 The Perkin-Elmer Corporation Method of detecting organisms in a sample
US5915307A (en) * 1998-01-29 1999-06-29 Suncast Corporation Sports shelf
NO311807B1 (no) * 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
US6399067B1 (en) * 2000-04-28 2002-06-04 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US6818392B2 (en) * 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
US7563437B2 (en) 2005-02-15 2009-07-21 Thymon, Llc Methods and compositions for impairing multiplication of HIV-1
US20080108054A1 (en) * 2006-08-28 2008-05-08 Jayasri Basu Detecting early HIV infection in genital tract cells and secretions
EP3187585A1 (de) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv-glycoproteine und rekombinante vektoren
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
CN110669133A (zh) * 2019-10-18 2020-01-10 普健生物(武汉)科技有限公司 利用尾静脉注射进行基因免疫开发小鼠单克隆抗体的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences

Also Published As

Publication number Publication date
KR890701771A (ko) 1989-12-21
IE61241B1 (en) 1994-10-19
IL87535A (en) 1993-01-14
AU2133788A (en) 1989-06-01
IE881799L (en) 1989-05-06
ES2016427A6 (es) 1990-11-01
CN1025219C (zh) 1994-06-29
DE3854502D1 (de) 1995-10-26
ZA884651B (en) 1990-03-28
KR960016304B1 (ko) 1996-12-09
JPH03500483A (ja) 1991-02-07
US4888290A (en) 1989-12-19
EP0415920A1 (de) 1991-03-13
JP2710972B2 (ja) 1998-02-10
AU612686B2 (en) 1991-07-18
WO1989004376A1 (en) 1989-05-18
IL87535A0 (en) 1989-01-31
CA1339350C (en) 1997-08-26
EP0415920A4 (en) 1993-03-17
CN1033071A (zh) 1989-05-24
EP0415920B1 (de) 1995-09-20

Similar Documents

Publication Publication Date Title
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE3883899T2 (de) Geänderte antikörper.
DE68914244D1 (de) Monoklonaler Antikörper.
DE69018801D1 (de) Chimärischer anti-cae-antikörper.
DE3879452D1 (de) Chimaere antikoerper.
DK666389A (da) Monoklonalt antistof
DE3885355D1 (de) Monoklonale Antikörper.
DE3889062T2 (de) Monoklonaler Antikörper gegen humanen BCDF.
NO894444L (no) Anti-fucosylceramid monoklonalt antistoff.
DE3888437T2 (de) Immobilisierte Antikörper.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK717888A (da) Monoklonale antistoffer
NO873488L (no) Monoklonale antistoffer.
NO890116D0 (no) Monoklonale antistoffer.
DK474189A (da) Monoklonalt antistof
DE68912772T2 (de) Monoklonaler antikörper gegen entero-viren.
DE69023717T2 (de) Monoklonaler Antikörper.
FI893928A0 (fi) Monoklonala motkroppar.
DE69020315T2 (de) Monoklonaler antikörper gegen c-reaktives protein.
DE3787416D1 (de) Monoklonaler Antikörper gegen Laforakörper.
DE68916088D1 (de) Anti-CPBII-monoklonaler Antikörper.
ATE87031T1 (de) Chimaere antikoerper.
DE3882066D1 (de) Monoclonaler antikoerper gegen menschliches lungenadenokarzinom.
ATE94171T1 (de) Geaenderte antikoerper.
NO885392L (no) Humant tumor-assosiert antigen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: COULTER INTERNATIONAL CORP., MIAMI, FLA., US